tulobuterol has been researched along with salmeterol xinafoate in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tamura, G | 1 |
| Aizawa, H; Fukuchi, Y; Hirata, K; Ichinose, M; Kubo, K; Nagai, A; Nishimura, M; Seyama, K | 1 |
| Fujimoto, K; Komatsu, Y; Kubo, K; Urushihata, K; Yasuo, M | 1 |
| Kato, K; Kimura, T; Kondoh, Y; Kume, H; Nishiyama, O; Shimokata, K; Taniguchi, H | 1 |
| Kita, H; Kobayashi, Y; Kudou, M; Yasuba, H | 1 |
| Akamatsu, K; Hirano, T; Ichikawa, T; Ichinose, M; Matsunaga, K; Minakata, Y; Nakanishi, M; Sugiura, H; Ueshima, K; Yamagata, T; Yanagisawa, S | 1 |
| Higashihara, K; Mochizuki, H; Nanjo, Y; Noguchi, T; Sugawara, T; Takahashi, H; Tsuda, Y; Yamazaki, M | 1 |
| Kawate, E; Mochizuki, H; Nanjo, Y; Takahashi, H; Tsuda, Y; Yamazaki, M | 1 |
| Mochizuki, H; Nanjo, Y; Takahashi, H | 1 |
| Inoue, H; Ito, I; Iwata, T; Matsumoto, H; Mishima, M; Nagasaki, T; Nakaji, H; Niimi, A; Oguma, T; Otsuka, K; Tajiri, T; Takeda, T | 1 |
1 review(s) available for tulobuterol and salmeterol xinafoate
| Article | Year |
|---|---|
[Long-acting beta 2-stimulants].
Topics: Administration, Cutaneous; Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchodilator Agents; Clinical Trials as Topic; Drug Therapy, Combination; Ethanolamines; Formoterol Fumarate; Humans; Salmeterol Xinafoate; Terbutaline; Time Factors | 2001 |
9 trial(s) available for tulobuterol and salmeterol xinafoate
| Article | Year |
|---|---|
Clinical efficacy and safety of transdermal tulobuterol in the treatment of stable COPD: an open-label comparison with inhaled salmeterol.
Topics: Administration, Cutaneous; Administration, Inhalation; Adult; Aged; Albuterol; Bronchodilator Agents; Female; Humans; Male; Middle Aged; Patient Compliance; Pulmonary Disease, Chronic Obstructive; Quality of Life; Salmeterol Xinafoate; Surveys and Questionnaires; Terbutaline; Time Factors | 2005 |
Comparison of the clinical efficacy of salmeterol and sustained-release tulobuterol (patch) on inadequately controlled asthma patients on inhaled corticosteroids.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Adult; Aged; Albuterol; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Male; Metered Dose Inhalers; Middle Aged; Peak Expiratory Flow Rate; Quality of Life; Salmeterol Xinafoate; Terbutaline; Treatment Outcome | 2006 |
Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma.
Topics: Administration, Cutaneous; Aged; Albuterol; Asthma; Bronchodilator Agents; Cross-Over Studies; Female; Humans; Male; Middle Aged; Random Allocation; Salmeterol Xinafoate; Terbutaline | 2006 |
Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler.
Topics: Administration, Cutaneous; Administration, Inhalation; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Androstadienes; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Drug Therapy, Combination; Fluticasone; Forced Expiratory Volume; Humans; Middle Aged; Patient Compliance; Patient Satisfaction; Salmeterol Xinafoate; Terbutaline | 2007 |
Comparison of bronchodilatory properties of transdermal and inhaled long-acting beta 2-agonists.
Topics: Administration, Cutaneous; Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aged; Albuterol; Cross-Over Studies; Delayed-Action Preparations; Female; Humans; Male; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Salmeterol Xinafoate; Technology, Pharmaceutical; Terbutaline | 2008 |
Comparison of adherence and efficacy between inhaled salmeterol and transdermal tulobuterol patch in elderly patients with chronic obstructive pulmonary disorder.
Topics: Administration, Cutaneous; Administration, Inhalation; Aged; Albuterol; Bronchodilator Agents; Cross-Over Studies; Female; Humans; Male; Patient Compliance; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Terbutaline; Treatment Outcome | 2009 |
β2-adrenergic receptor haplotype may be associated with susceptibility to desensitization to long-acting β2-agonists in COPD patients.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aged; Albuterol; Cross-Over Studies; Drug Tolerance; Female; Haplotypes; Humans; Male; Pharmacogenetics; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Terbutaline; Time Factors; Transdermal Patch; Treatment Outcome; Walking | 2012 |
Better adherence to a transdermal tulobuterol patch than inhaled salmeterol in elderly chronic obstructive pulmonary disease patients.
Topics: Administration, Cutaneous; Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Age Factors; Aged; Aged, 80 and over; Albuterol; Cross-Over Studies; Exercise Tolerance; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Inspiratory Capacity; Male; Maximal Midexpiratory Flow Rate; Medication Adherence; Mental Status Schedule; Pulmonary Diffusing Capacity; Pulmonary Disease, Chronic Obstructive; Quality of Life; Residual Volume; Salmeterol Xinafoate; Spirometry; Terbutaline; Total Lung Capacity; Treatment Outcome; Vital Capacity; Walking | 2013 |
A 12-week, randomized, parallel-group, proof-of-concept study of tulobuterol patch and salmeterol inhaler as add-on therapy in adult-onset mild-to-moderate asthma.
Topics: Adult; Aged; Asthma; Bronchodilator Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Salmeterol Xinafoate; Spirometry; Terbutaline; Transdermal Patch | 2017 |